KevinMD April 8, 2023
In this episode, we discuss personalized medicine with guest Ketan Desai, a physician-executive. We explore how Henry Ford’s mass production method influenced the pharmaceutical industry, and how personalized medicine presents new challenges. CAR T-cell therapy is an example of personalized medicine, but it cannot be mass-produced and is expensive, costing up to $1 million per patient. We examine the pushback against excessive healthcare spending and how the high cost of personalized medicine may lead to a need for balance between innovation and practicality. Join us as we delve into the future implications of personalized medicine.
Ketan Desai is a physician-executive.
He shares his story and discusses his KevinMD article, “Can personalized medicine live up to its hype in health care?”
...